retatrutide type 2 diabetes phase 2 trial A new weight-loss drug called is generating excitement after clinical participants lost an average of 30% of their body weight, results that rival or even exceed weight-loss surgery. Researchers also Retatrutide benefits in obesity, type

Bohn B, Herbst A, Pfeifer M et al (2015) Impact of physical activity on glycemic control and prevalence of cardiovascular risk factors in adults with type 1 diabetes: a cross-sectional multicenter study of 18,028 patients

Off-label use for the management of binge eating disorder is thought to minimize obsessive thoughts about food and binging urges

But while GLP-1 coverage for obesity treatment is the focus of the clinical and financial assessments and decisions for coverage, the clinical reality is that GLP-1 medications are also recommended for certain high-risk type 2 diabetes (T2DM)

California officials would not say how much it could save under the TrumpRx plan, citing federal and state restrictions on disclosing rebate information

Lean protein sources can help increase GLP-1 levels while also preventing muscle loss during weight loss

Those GLP-1s have been approved by the Food and Drug Administration for weight loss